featured
Novel HER2 Kinase Domain Mutations and Resistance to HER2-Targeted Therapies in Human Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer
Clin. Cancer Res 2016 Oct 01;22(19)4859-4869, WJ Zuo, YZ Jiang, YJ Wang, XE Xu, X Hu, GY Liu, J Wu, GH Di, KD Yu, ZM ShaoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.